E5 Acupuncture Limited 31/07/2020 iXBRL
E5 Acupuncture Limited 31/07/2020 iXBRL
Company registration number:
10268725
Contents
Directors and other information
Income statement
Statement of financial position
Directors and other information
Directors |
|
|
|
||
Company number |
|
|
Registered office |
|
|
|
||
|
||
|
||
|
||
Business address |
|
|
|
||
|
||
Accountants |
|
|
Chartered Accountants | ||
2 Ocean Heights | ||
22 Boscombe Cliff Road | ||
Bournemouth | ||
BH5 1LA | ||
Income statement
Year ended 31 July 2020
2020 | 2019 | ||||
£ | £ | ||||
Turnover |
|
|
|||
Cost of raw materials and consumables |
(
|
(
|
|||
Staff costs |
(
|
(
|
|||
Depreciation and other amounts written off assets |
(
|
(
|
|||
Other charges | (18,283) | (28,171) | |||
Tax |
(
|
(
|
|||
_______ | _______ | ||||
Profit |
|
|
|||
_______ | _______ | ||||
Statement of financial position
31 July 2020
2020 | 2019 | ||||
£ | £ | ||||
Fixed assets |
|
|
|||
_______ | _______ | ||||
Current assets |
|
|
|||
Creditors: amounts falling due within one year |
(
|
(
|
|||
_______ | _______ | ||||
Net current assets |
|
|
|||
_______ | _______ | ||||
Total assets less current liabilities |
|
|
|||
Creditors: amounts falling due after more than one year |
(
|
- | |||
Accruals and deferred income |
(
|
(
|
|||
_______ | _______ | ||||
Net assets |
|
|
|||
_______ | _______ | ||||
Capital and reserves |
|
|
|||
_______ | _______ | ||||
Year ended 31 July 2020
Directors responsiblities:
-
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These financial statements were approved by the
board of directors
and authorised for issue on
07 December 2020
, and are signed on behalf of the board by:
Director
Company registration number:
10268725
The company is a private company limited by shares, registered in England.